Neoantigens may have the ability to provoke the immune system into recognizing and killing cancer cells in patients with multiple myeloma.
Although CAR-T therapies have shown favorable response rates, they can be incredibly costly and may not be priced in alignment with their benefits.
Researchers reviewed the diagnosis and management of several pregnancy-specific causes of thrombocytopenia.
Ten different drugs continued to kill cancer cells even when their target proteins were removed.
Although gene therapy shows promise in curing hemophilia, questions about its efficacy, optimal administration, and outcomes remain.